Welcome to our dedicated page for Azenta news (Ticker: AZTA), a resource for investors and traders seeking the latest updates and insights on Azenta stock.
Azenta Inc (Nasdaq: AZTA) is a global leader in life sciences solutions, providing essential tools for drug development, clinical research, and genomic discovery. This page aggregates official press releases and verified news about the company’s advancements in cold-chain sample management, automated storage systems, and multiomics services.
Investors and researchers will find timely updates on Azenta’s operational milestones, including earnings reports, strategic partnerships, product innovations, and industry recognition. The curated content addresses key areas such as sample integrity technologies, genomic data accuracy, and global service expansions.
Key updates include developments from Azenta’s core segments: Life Sciences Products (automated storage solutions, lab consumables) and Life Sciences Services (genomic sequencing, multiomics analytics). Content is organized to help stakeholders track progress in critical research areas like precision medicine and biotherapeutic development.
Bookmark this page for streamlined access to Azenta’s latest announcements, or check regularly for insights into how the company continues to shape the future of life sciences infrastructure and biomedical innovation.
Azenta, Inc. (Nasdaq: AZTA) announced its participation in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on March 22, 2022. The event will feature a presentation at 3:00 PM ET in a virtual format, accessible via Azenta's investor relations website.
Azenta specializes in life sciences solutions, offering cold-chain sample management and genomic services for drug development and clinical research. The company rebranded from Brooks Automation, Inc. on December 1.
Azenta, Inc. (Nasdaq: AZTA) will participate in the Barclays Global Healthcare Conference on March 15, 2022, with a presentation at 10:15am ET. The event takes place in Miami, FL, and a live webcast is available on Azenta's investor relations website. A replay will also be accessible post-event. Azenta specializes in life sciences solutions, offering cold-chain sample management and genomic services. The company rebranded from Brooks Automation on December 1, adopting the new name and ticker symbol.
Azenta, Inc. (Nasdaq: AZTA) will participate in Cowen's 42nd Annual Health Care Conference on March 8, 2022, with a live presentation at 2:10 PM ET. The conference will be held virtually, and interested parties can access the live webcast via the Azenta investor relations website. A replay will be available after the event. Azenta is a global leader in life sciences solutions, providing cold-chain sample management and genomic services to the pharmaceutical and biotech industries.
Azenta, Inc. (Nasdaq: AZTA) reported Q1 fiscal 2022 results with revenue of $140 million, an 18% increase year-over-year. Life Sciences Services grew 24%, while Life Sciences Products saw a 10% rise. Diluted EPS from continuing operations was $0.04, with total diluted EPS at $0.58. The company completed the divestiture of its semiconductor automation business for $3 billion, expected to net about $2.4 billion. Guidance for Q2 2022 anticipates revenue between $137 million and $147 million, with non-GAAP earnings per share between $0.07 and $0.15.
Azenta, Inc. (Nasdaq: AZTA) will participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 15, 2022, presenting at 10:30 a.m. EST. The company, a leader in life sciences solutions, recently rebranded from Brooks Automation, enhancing their focus on critical areas like drug development and clinical research.
Headquartered in Chelmsford, MA, Azenta aims to expedite breakthroughs in healthcare through reliable cold-chain sample management and genomic services. For details, visit www.azenta.com.
Azenta, Inc. (Nasdaq: AZTA) announced the successful completion of the sale of its Semiconductor Solutions Group to Thomas H. Lee Partners for $3.0 billion in cash, with net proceeds expected to be about $2.4 billion. The company allocated approximately $50 million of the sale proceeds to pay off its term loan, while terminating its revolving line of credit. Following this transaction, Azenta will concentrate exclusively on the life sciences industry, planning to utilize the net proceeds for strategic investments.
Azenta, Inc. (Nasdaq: AZTA) will announce its fiscal 2022 Q1 earnings on February 8, 2022, after market close. A conference call to discuss the results will be held the same day at 4:30 p.m. ET. Investors can access the live webcast on Azenta's website, with a replay available on February 9 at 8:30 a.m. ET. The company, a leader in life sciences solutions, has rebranded from Brooks Automation, Inc. and is in the process of selling its Semiconductor Solutions Group business, which is classified as discontinued operations for reporting purposes.
Azenta, Inc. (Nasdaq: AZTA) appointed Matthew McManus as Chief Operating Officer, effective January 17, 2022. Dr. McManus, with over 25 years in the life sciences sector, will oversee Life Sciences Products, Services, and commercial operations, reporting directly to the CEO. He previously held senior roles at Bio-Techne and Asuragen. The company has transitioned its name and ticker from Brooks Automation, Inc. to Azenta as of December 1.
Azenta specializes in life sciences solutions, including cold-chain sample management and genomic services.
Azenta, Inc. (Nasdaq: AZTA) will participate in the 40th Annual J.P. Morgan Healthcare Conference on January 12, 2022, at 3:45 p.m. EST. The conference will be held virtually, and the presentation can be accessed through the Azenta investor relations website. A replay will be available post-event. Recently rebranded from Brooks Automation, Azenta provides life sciences solutions and cold-chain sample management services globally. The company is headquartered in Chelmsford, MA, and operates in North America, Europe, and Asia.
Azenta, Inc. (Nasdaq: AZTA) announced its participation in the 24th Annual Needham Virtual Growth Conference on January 10, 2022, with a webcast starting at 1:15 p.m. EST. The event will be accessible via the Azenta investor relations website, with a replay available afterward.
Previously known as Brooks Automation, Inc., Azenta focuses on life sciences, offering cold-chain sample management and genomic services. The company also reports the Semiconductor Solutions Group as discontinued operations due to a pending sale.
